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Abstract 
Background: Various strategies have been proposed to minimize reperfusion delay in patients who are candidate 
for primary percutaneous coronary intervention (PCI). Reperfusion time may be affected by both intra- and extra-
hospital factors. The study attempted to identify factors affecting reperfusion time to reduce mortality and 
morbidity. 
Materials and Methods: In this cross-sectional study, 95 patients with chest pain who were admitted to a hospital 
emergency in Tehran (capital city of Iran) were admitted and those who were diagnosed with ST-segment 
elevation myocardial infarction (STEMI) were candidates for primary PCI. Basic information was asked from 
the patients or companion of them. In addition, the PCI time recorded in the patient file was entered in the 
checklist. 
Results: The mean interval between the onset of symptoms and primary PCI was 218.6±21.69 min. The interval 
between the first medical contact (FMC) and primary PCI was determined to be 87.122±183.66 minutes. The 
mean time of door to balloon in the hospital was 42.49±78.53 min. In addition, the mean time interval from 
symptom onset to FMC was 19.47±11.84 minutes. In 31 cases (32.6%), the emergency service (EMS) 
contacted. Three factors were identified to be associated with a delay between the onset of symptoms to 
primary PCI (or delay reperfusion time) including the previous history of myocardial infarction (MI) 
(p=0.034), the severity of coronary artery disease, based on angiography (p=0.043) and the type of vehicle 
used to transfer the patient to the hospital (p=0.007). 
Conclusion: The reperfusion delay seems to be higher in our treatment center than in other centers. Three 
preceding factors of MI, the severity of coronary artery disease and the transmission of patients via EMS are 
considered factors associated with the reduction of reperfusion delay. 
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Introduction 
The primary percutaneous coronary intervention 
(PCI) procedure is currently considered as a 
predominant strategy in the treatment of acute 
myocardial infarction (MI) associated with ST-
segment elevation (STEMI) when it is done in due time 
by an experienced operator. This technique has far more 
satisfactory results than thrombolytic treatment, even 
when the time interval between the event and hospital 
transferring is prolonged1-6. Delaying reperfusion in 
determining the prognosis of patients with STEMI, play 
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an important role. In this regard, both the time interval 
between the patient's arrival to the percutaneous 
coronary intervention (PCI) lab (door to balloon time) 
and total ischemic time relate to the increased risk for 
motility in most patients7-9. New guidelines have 
suggested that the delay in door to balloon time should 
be reduced to less than 90 to 120 minutes10,11. 
However, latencies in performing the primary PCI are 
usually longer than those given in the guidelines12,13 
and this makes the primary therapeutic effects of PCI 
less effective than thrombolysis14,15. To solve this 
problem, various strategies have been proposed, and 
national steps, especially in Europe and America, have 
been taken to manage time in the primary PCI process. 
All of these strategies are aimed at bypass of the 
emergency services (EMS), the faster transferring the 
patient to the catheter lobe and also minimizing the 
delay time in the reperfusion. 
In the treatment of patients with STEMI, the goal is to 
open the access in the artery to supply the ischemic 
tissue with either a thrombolytic drug or PCI. Factors 
that cause reperfusion delay include pre-hospital delay 
(due to advanced age, previous history of MI, referral 
by personal vehicle and no contact with EMS), and 
intra-hospital delay due to prolonged door to Balloon 
Time16,17. Information to emergency centers is one of 
the most important steps that should be taken by the 
patient. Patients with STEMI should receive 
emergency coronary reperfusion within 12 hours18. 
The more reperfusion is done sooner, the more health 
benefits are gained and the mortality rate is reduced. 
Current guide lines recommend that the time between 
the first medical contact with the patient and the 
balloon during angioplasty should not be over 90 
minutes19.  This time may be affected by both intra- 
and extra-hospital factors that should be clearly 
identified to minimize this time interval20. The study 
attempted to identify factors affecting reperfusion 
time to reduce mortality and morbidity. In total, the 
following questions were answered in this study: 
What is the frequency of reperfusion delay in STEMI 
patients under primary PCI? What is the TIMI flow 
grade based on what is observed at the primary PCI 




In this descriptive cross-sectional study, patients with 
chest pain who were admitted to an emergency ward of 
a hospital in Tehran (capital city of Iran) were admitted 
and those who were diagnosed with STEMI were 
candidates for primary PCI. Basic information 
including gender, age, previous history of heart disease, 
risk factors for heart disease (smoking, hypertension 
and diabetes) as well as the time for starting chest pain, 
the time interval between pain initiation and transfer to 
hospital, duration of treatment, and oral medications 
were asked from patients or companions. In addition, 
the PCI time was entered in the checklist. On the other 
hand, the severity of chest pain, type of pain, how it was 
disseminated and associated symptoms were also 
asked. During the course of angiography, TIMI flow 
rate was also recorded. 
The results were presented as mean±standard deviation 
(SD) for quantitative variables and were summarized by 
absolute frequencies and percentages for categorical 
variables. Normality of data was analyzed using the 
Kolmogorov-Smirnoff test. Categorical variables were 
compared using chi-square test or Fisher's exact test 
when more than 20% of cells with expected count of 
less than 5 were observed. Quantitative variables were 
also compared with t test or Mann U test. For the 
statistical analysis, the statistical software SPSS version 
16.0 for windows (SPSS Inc., Chicago, IL) was used 
and p values of 0.05 or less were considered statistically 
significant. 
Results 
Baseline characteristics of the study subjects were 
summarized in Table 1. A total of 95 patients were 
evaluated. The mean age of the patients was 
59.24±13.22 years old in the range of 28-86 years old 
and 83 (87.4%) patients were men and 12 (12.6%) were 
women. History of MI was found in 4.2%, 43.2% were 
hypertensive, 26.3% were diabetic, 27.4% had 
hyperlipidemia, 43.2% were smokers, and 4.2% were 
opium misuser. In addition, 6.3% had previous 
experience of PCI, 4.2% underwent coronary artery 
bypass grafting (CABG) previously, and 7.4% had 
history of brain stroke. Family history of heart disease 
was found in 21.1% and only 1.1% was obese. History 
of cardiac care unit (CCU) admission was found in 
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84.2%. Regarding severity of coronary artery disease 
(CAD), one, two and three-vessel disease based on 
angiography was revealed in 32.6%, 36.8% and 30.5% 
respectively. Overall, 26.3% had left ventricular 
ejection fraction (LVEF) lower than 35%. Regarding 
functional status, Killip class I, II, III, and IV was 
found in 82.1%, 10.5%, 6.3%, and 1.1% respectively.   
Regarding thrombolysis in myocardial infarction 
(TIMI) flow before PCI, TIMI 0 was found in 86.3%, 
TIMI I in 1.1%, TIMI II in 10.5%, and TIMI III in 
2.1%, while these rates after PCI were 0%, 1.1%, 
7.4%, 91.6%. The mean TIMI frame count was also 
16.77±2.55. In total, 24.2% underwent thrombectomy.   
The mean interval between the onset of symptoms and 
primary PCI was 218.6±21.69 min. The interval 
between the first medical contact (FMC) and primary 
PCI was determined to be 87.122±183.66 minutes. 
The mean time of door to balloon in the hospital was 
42.49±78.53 min. Also, the mean time interval from 
symptom onset to FMC was 19.47±11.84 minutes. In 
31 cases (32.6%), the EMS service was contacted. The 
centers covered by FMC cases included government 
centers in 2 cases (1.2%), private clinics in 4 cases 
(4.2%), other hospitals in 22 cases (23.2%) and referred 
hospital in 67 cases (70.6%). The use of motor vehicles 
also recorded as personal cars in 59 (62.1%), taxi 
service in 4 cases (4.2%) and EMS in 32 cases (33.7%).  
Based on the multivariate linear regression model and 
the presence of all the underlying factors of the study, 
there were three factors in total associated with a delay 
between the onset of symptoms to primary PCI (or 
delay reperfusion time). They included the previous 
history of MI (p=0.034), the severity of coronary artery 
disease, based on angiography (p=0.043), and the type 
of vehicle used to transfer the patient to the hospital 
(p=0.007). In this regard, the mean time between the 
onset of symptoms and primary PCI in patients with and 
without previous history of MI was 155.1±91.88 
Table 1: Baseline characteristics of study population. 
Mean age, year 59.42 ± 13.22 
Gender  
Male 83 (87.4) 
Female  12 (12.6) 
Occupation state   
Employed  16 (16.8) 
Worker 8 (8.4) 
Self-employed  35 (36.8) 
Housekeeper  10 (10.5) 
Retired  24 (25.3) 
Farmer  2 (2.1) 
Marital status   
Married  87 (91.6) 
Single  2 (2.1) 
Divorced  3 (3.2) 
Widow  3 (3.2) 
Educational level  
Illiterate  9 (9.5) 
Primary  16 (16.8) 
Secondary  7 (7.4) 
Diploma  36 (27.4) 
Bachelor  22 (23.2) 
Master 2 (2.1) 
Doctorate  3 (3.2) 
Living alone  4 (4.2) 
Having insurance  75 (78.9) 
 
 
Table 2: Cardiovascular variables of study population. 
Primary complaint   
Typical chest pain  73 (76.8) 
Atypical chest pain  1 (1.1) 
Non-specific chest pain  21 (22.1) 
Medical history   
Myocardial infarction  4 (4.2) 
Hypertension  41 (43.2) 
Diabetes  25 (26.3) 
Hyperlipidemia 26 (27.4) 
Smoking  41 (43.2) 
Opium use  4 (4.2) 
Previous PCI 6 (6.3) 
Previous CABG 4 (4.2) 
Previous brain stroke  7 (7.4) 
Family history of heart disease 20 (21.1) 
Obesity  1 (1.1) 
CCU admission   
Once 9 (9.5) 
Twice  4 (4.2) 
Three times  2 (2.1) 
Angiography report   
One vessel 31 (32.6) 
Two vessels  35 (36.8) 
Three vessels  29 (30.5) 
LVEF  
< 35% 25 (26.3) 
35 – 50% 49 (51.6) 
> 50% 21 (22.1) 
Killip class   
I 78 (82.1) 
II 10 (10.5) 
III 6 (6.3) 
IV 1 (1.1) 
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minutes and 2886.07±27.62 minutes, respectively, 
that was lower in the group with previous history of 
MI. Also, the mean time between the onset of 
symptoms and primary PCI in patients with single 
coronary involvement was 2645.16±19.27 minutes, in 
cases with two-vessel involvement was 258.4±166.53 
min, and in the cases with three vessels involvement 
was 347.41±264.97 minutes, which increased with 
increasing number of involved vessels. The average 
time between the onset of symptoms and primary PCI 
in patients with transmission using personal vehicle 
was 327.29 236.66 minutes, in the cases of using the 
taxi service to be 290.22±21.66 minutes, and in the case 
of EMS use was 160.55±180.33 minutes, which was the 
shortest related to the use of EMS. The mean time 
between the onset of symptoms and primary PCI in men 
and women was 264.46±11.122 min and 396.62±38.31 
min, respectively with no statistical significant 
difference. In addition, there was no significant 
correlation between the time between the onset of 
symptoms and primary PCI with the age of the patients 
(correlation coefficient equal to 0.109, p=0.295). The 
mean time between the onset of symptoms and primary 
PCI in hypertensive and normotensive groups was 
259.75±26.26 and 129.29±49.26 minutes, respectively, 
which did not differ between the two groups (p=0.427). 
The mean of this time in patients with and without 
diabetes mellitus was 336.38±25.88 and 272.85±229.26 
minutes, respectively, which did not differ between the 
two groups (p=0.352). Similarly, the mean pointed time 
in those with and without hyperlipidemia was 
277.50±244.81 minutes and 282.53±28.42 minutes 
respectively (p=0.925). The mean time between the 
onset of symptoms and primary PCI in patients with and 
without smoking history were 288.88±250.88 and 
272.26±226.22, respectively, which did not differ 
between the two groups (p=0.910).  
Based on the multivariate linear regression model, none 
of the underlying factors was able to predict other times, 
including the interval between the first medical contact 
(FMC) and primary PCI, the door to balloon time in the 
hospital, or the time interval between the occurrence of 
the symptoms and the FMC. 
Discussion 
In various studies, the time interval between the clinical 
manifestations of STEMI occurrence prior to the 
primary PCI procedure is considered as an important 
prognostic factor, especially hospital mortality in these 
patients. In this regard, studies have evaluated various 
factors predicting this delay to minimize the time gap to 
improve PCI-related implications. In this regard, the 
present study aimed to investigate the delayed 
reperfusion of primary PCI in patients with STEMI and 
in this regard, factors that are positively associated with 
increasing delay in reperfusion were assessed. At the 
beginning of the study, we found that the mean time 
interval between the onset of symptoms and primary 
PCI was 238.16±31.69 minutes. The interval between 
Table 3: Multivariate linear regression model to 
determine the correlates of delayed reperfusion time. 
Factor   Beta  T score P value 
Age  1.557 0.631 0.530 
Gender  131.95 1.403 0.165 
Job  -23.210 -1.028 0.307 
Marital 48.144 0.697 0.488 
Education level 6.397 0.349 0.728 
Living alone -14.785 -0.190 0.850 
Insurance  -42.018 -0.657 0.513 
Income  -42.372 -1.418 0.161 
Previous MI 314.424 2.165 0.034 
Hypertension  15.956 0.289 0.774 
Diabetes  -77.563 -1.248 0.216 
Hyperlipidemia  51.563 0.819 0.416 
Smoking  2.936 0.116 0.908 
Opium use -12.197 -1.051 0.297 
Previous PCI 112.766 0.757 0.451 
Previous CABG 50.589 0.389 0.699 
Previous stroke -25.347 -0.242 0.810 
Family history of 
CAD 
-68.768 -1.084 0.282 
CCU admission 46.076 0.754 0.436 
Severity of CAD 76.576 2.064 0.043 
Type of MI -4.547 -0.381 0.704 
LVEF 9.891 0.244 0.808 
Killip class 61.712 1.438 0.155 
FMC -0.576 -0.112 0.911 
Type of 
transferring 
-69.417 -2.769 0.007 
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the FMC and primary PCI was determined to be 
87.122±183.66 minutes. The mean time of door to 
balloon in the hospital was also 42.49±78.53 min. In 
addition, the mean time interval from symptom to 
FMC was 19.47±11.84 minutes. According to a 
review of related studies, the door to balloon interval 
was equivalent to other studies. For example, 
according to the instructions given, the optimal time 
for door to balloon is considered less than 90 to 120 
minutes. In our study, 96.8% of patients had a door to 
balloon time of less than 105 minutes. However, the 
time of reperfusion delay or the interval between the 
onset of symptoms and primary PCI was higher in our 
study than in other studies and it was varying between 
35 and 990 minutes. The major reason for this delay 
was that, firstly, many of the patients referred to the 
center were due to their referral from surrounding 
cities and even distant areas and therefore, long 
distance between clinical symptoms and PCI increases 
significantly. Second, due to the non-specificity of 
symptoms and clinical manifestations in most of 
patients, patients who referred to the hospital or 
contact with the EMS delayed and sometimes even 
until 24 hours after the onset of symptoms referral to 
health centers. 
In the second step, and in evaluating the factors 
associated with delayed reperfusion and the PCI 
process, we found that patients with a history of MI 
had a much lower latency for reperfusion. It is due to 
the greater awareness of patients with a history of MI 
of prominent manifestations, as well as to the need for 
quick referral for treatment as soon as possible for 
these patients. In addition, with increasing severity of 
coronary artery disease, the latency of PCI also 
increases that may be due to the more delayed these 
patients in emergency centers for initial evaluations. 
As it has been mentioned in some studies, the initial 
referral of patients to emergency centers is a factor in 
increasing the delay in referring patients to cat lab.  
As a third factor in predicting reperfusion delay, the 
patient's transfer to hospital is an effective factor to 
increase the delay. Because it is evident that the EMS 
referral is accompanied with the lowest delay and 
personalized referrals has the greatest delays, since 
EMS is trying to minimize this time in coordination 
with the patient accepting centers for the PCI. While 
transferring through personal methods in coordination 
with the receiving centers would make it impossible to 
move between different centers to the final receiving 
center. 
In total, the reperfusion delay predictive factors were 
different in different studies. In the study of 
Blankenship et al., the most important factors related to 
the interval between the onset of symptoms and the 
arrival of the PCI hospital, as well as the door to balloon 
time, were the initial transfer of patients to non-PCI 
centers, which is equivalent to the analysis we have just 
mentioned. In addition, the referral of the patient with 
the symptoms of respiratory distress, the referral of 
patients to non-adherent clocks and the presence of 
comorbidities such as diabetes and heart failure were 
predictors that were not considered as prognostic 
factors in our study21. In the study of Rodríguez-Leor et 
al., the shortest total delaying time was related to the 
use of EMS, which was completely consistent with our 
study22. In the study of Shavelle et al., the factors 
associated with delay in the onset of treatment include 
referral in days and unannounced dates and shutting 
down, failure to perform ECG within 10 minutes of 
hospitalization, previous CABG history, black race, 
older age, and female gender. The only previous history 
of MI in our study was consistent with this study23. 
Conclusion 
Overall, the reperfusion delay seems to be higher in our 
treatment center than in other centers. Based on the 
analysis, the three preceding factors of MI, the severity 
of coronary artery disease and the transmission of 
patients via EMS are considered factors associated with 
the reduction of reperfusion delay. Therefore, by 
evaluating the clinical history of patients as well as 
initial evaluation of patients through 
electrocardiographic evaluation during transmission 
with EMS, the time for transferring to clinical settings 
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